Alphabet Inc. Verve Therapeutics, Inc. Transaction History
Alphabet Inc.
- $2.25 Billion
- Q1 2024
A detailed history of Alphabet Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 12,349,086 shares of VERV stock, worth $64.1 Million. This represents 7.28% of its overall portfolio holdings.
Number of Shares
12,349,086
Previous 12,349,086
-0.0%
Holding current value
$64.1 Million
Previous $172 Million
4.73%
% of portfolio
7.28%
Previous 8.63%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
169Shares Held
78.3MCall Options Held
125KPut Options Held
185K-
Vanguard Group Inc Valley Forge, PA6.33MShares$32.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.04MShares$31.4 Million0.57% of portfolio
-
Black Rock Inc. New York, NY5.37MShares$27.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.1MShares$26.5 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.58MShares$23.8 Million0.04% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $311M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...